Dtic-dome and Pulmonary embolism - a phase IV clinical study of FDA data

Summary:

Pulmonary embolism is found among people who take Dtic-dome, especially for people who are male, 50-59 old.

The phase IV clinical study analyzes which people take Dtic-dome and have Pulmonary embolism. It is created by eHealthMe based on reports of 206 people who have side effects when taking Dtic-dome from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Nov, 24, 2022

206 people reported to have side effects when taking Dtic-dome.
Among them, 11 people (5.34%) have Pulmonary embolism.


What is Dtic-dome?

Dtic-dome has active ingredients of dacarbazine. eHealthMe is studying from 206 Dtic-dome users for its effectiveness, alternative drugs and more.

What is Pulmonary embolism?

Pulmonary embolism (blockage of the main artery of the lung) is found to be associated with 3,257 drugs and 2,794 conditions by eHealthMe.

Number of Dtic-dome and Pulmonary embolism reports submitted per year:

Could Dtic-dome cause Pulmonary embolism?

Gender of people who have Pulmonary embolism when taking Dtic-dome*:

Click here to view

Age of people who have Pulmonary embolism when taking Dtic-dome *:

Click here to view

Common drugs people take besides Dtic-dome *:

Click here to view

Common side effects people have besides Pulmonary embolism *:

Click here to view

Common conditions people have *:

Click here to view

* Approximation only. Some reports may have incomplete information.

Do you take Dtic-dome and have Pulmonary embolism?

Check whether Pulmonary embolism is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

How severe was Pulmonary embolism and when was it recovered:

Expand to all the drugs that have ingredients of dacarbazine:

Alternative drugs to, pros and cons of Dtic-dome:

Pulmonary embolism treatments and more:

COVID vaccines that are related to Pulmonary embolism:

Common drugs associated with Pulmonary embolism:

All the drugs that are associated with Pulmonary embolism:

Common conditions associated with Pulmonary embolism:

All the conditions that are associated with Pulmonary embolism:

How the study uses the data?

The study uses data from the FDA. It is based on dacarbazine (the active ingredients of Dtic-dome) and Dtic-dome (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: